Motif ID: Hinfp
Z-value: 1.764

Transcription factors associated with Hinfp:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hinfp | ENSMUSG00000032119.4 | Hinfp |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hinfp | mm10_v2_chr9_-_44305595_44305688 | -0.44 | 4.2e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 18.7 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
2.4 | 4.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.3 | 6.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.2 | 15.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.2 | 10.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.7 | 5.2 | GO:0001757 | somite specification(GO:0001757) arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.7 | 6.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) negative regulation of low-density lipoprotein particle clearance(GO:0010989) positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
1.6 | 12.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.6 | 4.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.5 | 12.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.5 | 7.5 | GO:0019659 | fermentation(GO:0006113) lactate biosynthetic process from pyruvate(GO:0019244) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.5 | 4.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.4 | 5.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.4 | 5.4 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
1.2 | 3.7 | GO:0030421 | defecation(GO:0030421) |
1.0 | 5.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.0 | 2.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 3.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.8 | 2.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.8 | 3.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.8 | 3.1 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.8 | 2.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.8 | 3.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 2.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.7 | 3.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.7 | 3.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.7 | 7.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 10.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 2.4 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.6 | 1.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 2.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 2.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.5 | 2.6 | GO:0090669 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
0.5 | 3.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 4.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 5.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 1.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.4 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 2.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 5.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 2.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 8.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.4 | 3.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 2.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 1.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 3.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 3.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 1.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 5.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.9 | GO:0002554 | serotonin secretion by platelet(GO:0002554) interleukin-3 production(GO:0032632) beta selection(GO:0043366) |
0.3 | 1.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.5 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 0.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 1.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 2.5 | GO:1990173 | protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 1.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 2.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 2.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.2 | 1.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 5.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 1.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.2 | 1.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.9 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 4.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.2 | 0.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 4.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 3.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 1.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 7.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 2.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 3.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 1.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 27.3 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.1 | 0.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 1.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 2.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 7.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 2.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 4.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 3.6 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 2.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 3.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 3.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 5.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 3.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 3.1 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 2.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 1.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 2.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 3.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 2.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 2.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 1.5 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 5.1 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.3 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 1.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 3.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 1.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 2.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 1.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 1.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.7 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.0 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 3.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 1.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 2.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.9 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 1.8 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 2.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 2.9 | GO:0042493 | response to drug(GO:0042493) |
0.0 | 1.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.8 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.7 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.8 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 1.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.6 | 15.6 | GO:0000796 | condensin complex(GO:0000796) |
1.4 | 5.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.2 | 3.6 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 3.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 5.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.8 | 3.1 | GO:0000939 | nuclear MIS12/MIND complex(GO:0000818) condensed chromosome inner kinetochore(GO:0000939) |
0.8 | 3.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 5.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 3.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 1.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 3.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 7.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 1.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 1.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.4 | 2.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.4 | 1.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 5.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 2.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 17.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.3 | 1.2 | GO:0090537 | CERF complex(GO:0090537) |
0.3 | 2.0 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.3 | 1.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 9.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 5.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 4.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 3.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.2 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 4.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 5.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 4.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 14.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 1.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 8.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 9.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 4.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 7.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 5.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 5.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 2.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 3.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 6.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 2.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 3.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 2.8 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 4.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 3.2 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 2.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 8.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 2.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 1.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 9.1 | GO:0030424 | axon(GO:0030424) |
0.0 | 2.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 7.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 3.9 | GO:0031012 | extracellular matrix(GO:0031012) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 23.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.5 | 9.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
2.3 | 6.8 | GO:0034190 | very-low-density lipoprotein particle binding(GO:0034189) apolipoprotein receptor binding(GO:0034190) |
1.9 | 7.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.9 | 5.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.7 | 12.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.5 | 5.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 4.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.1 | 4.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.9 | 5.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 3.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 7.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 2.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.7 | 4.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 2.5 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.6 | 13.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 3.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.5 | 2.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 2.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 5.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 3.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.3 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.4 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 3.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.4 | 2.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 2.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 2.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.3 | 5.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.9 | GO:0002135 | CTP binding(GO:0002135) |
0.3 | 5.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 8.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 3.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 1.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 16.8 | GO:0019955 | cytokine binding(GO:0019955) |
0.2 | 4.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 3.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 2.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 19.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 2.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 1.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 3.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 4.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 6.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 2.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 4.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 2.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 2.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 3.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 3.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 7.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 5.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.5 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 4.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 1.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 9.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 2.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 10.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 1.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 3.5 | GO:0008026 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) ATP-dependent helicase activity(GO:0008026) RNA-dependent ATPase activity(GO:0008186) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 2.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 3.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 3.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 3.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 1.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 14.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 5.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 1.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 13.6 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 18.0 | PID_BMP_PATHWAY | BMP receptor signaling |
0.3 | 12.3 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.3 | 12.6 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.3 | 2.6 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 10.3 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.2 | 9.1 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.1 | 3.6 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.1 | 14.1 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 6.0 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.5 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.1 | 6.6 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 5.0 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 12.2 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.9 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.5 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.1 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.9 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.4 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.5 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 2.3 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 2.9 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.6 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.0 | 1.8 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.9 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.6 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 18.0 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.5 | 12.0 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 15.0 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 5.2 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 6.1 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 5.4 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 1.2 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 6.3 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 3.1 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 4.0 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.1 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.2 | 4.9 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 3.3 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 4.3 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 3.4 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.3 | REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.2 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.4 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 10.2 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.5 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 5.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 3.6 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.1 | 1.0 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 2.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 5.1 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.9 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 5.7 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.5 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.5 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.6 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 14.3 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.2 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 3.6 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 3.5 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 2.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.6 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.1 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.0 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 1.0 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.2 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 2.6 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.9 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.1 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.8 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.0 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.9 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.5 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.1 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.1 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.9 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |